[1] Camp G, Willems PJ, Smith RJ. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet , 1997, 60(4): 758–764. [2] I, Gardner P. Hereditary sensorineural hearing loss: advances in molecular genetics and mutation analysis. Expert Rev Mol Diagn , 2006, 6(3): 375–386. [3] Y, Jiang X, Ito Y, Bringas P Jr, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development , 2000, 127(8): 1671–1679. [4] ML, Bronner-Fraser M. Neural crest inducing signals. Adv Exp Med Biol , 2006, 589: 24–31. [5] RP. Neurocristopathy: its growth and development in 20 years. Pediatr Pathol Lab Med , 1997, 17(1): 1–25. [6] PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet , 1951, 3(3): 195–253. [7] LA, Grundfast KM, Amos J, Arnos KS, Asher JH Jr, Beighton P, Diehl SR, Fex J, Foy C, Friedman TB, Greenberg J, Hoth C, Marazita M, Milunsky A, Morell R, Nance W, Newton V, Ramesar R, Agustin TB, Skare J, Stevens CA,Wagner RG, Wilcox ER, Winship I, Read AP. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am J Hum Genet , 1992, 50(5): 902–913. [8] WB, Stone VM, Boder E, Ziprkowski L. Pigmentary disorders in association with congenital deafness. Arch Dermatol , 1967, 95(2): 176–186. [9] CA, Nakayama A, Li H, Swenson LB, Opdecamp K, Asher JH Jr, Arnheiter H, Glaser T. Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2. Hum Mol Genet , 1998, 7(4): 703–708. [10] AP, Newton VE. Waardenburg syndrome. J Med Genet , 1997, 34(8): 656–665. [11] S. Genetic heterogeneity in the Waardenburg syndrome. Birth Defects Orig Artic Ser , 1971, 7(4): 87–101. [12] MJ, Delleman JW. Heterogeneity in Waardenburg syndrome. Am J Hum Genet , 1977, 29(5): 468–485. [13] LA, Arnos KS, Asher JH Jr, Baldwin CT, Diehl SR, Friedman TB, Greenberg J, Grundfast KM, Hoth C, Lalwani AK, Landa B, Leverton K, Milunsky A, Morell R, Nance WE, Newton V, Ramesar R, Rao VS, Reynolds JE, Agustin TBS, Wilcox ER, Winship I, Read AP. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes. Am J Hum Genet , 1994, 55(4): 728–737. [14] XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet , 1995, 55(1): 95–100. [15] R, Pavan WJ. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene , 2003, 22(20): 3024–3034. [16] LL, Hou L, Loftus SK, Pavan WJ. Spotlight on spotted mice: a review of white spotting mouse mutants and associated human pigmentation disorders. Pigment Cell Res , 2004, 17(3): 215–224. [17] RA, Chiang PW, Oiso N, Alkhateeb A. Human and mouse disorders of pigmentation. Curr Opin Genet Dev , 2003, 13(3): 284–289. [18] V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat , 2010, 31(4): 391–406. [19] JF, Trainor PA. Neural crest stem and progenitor cells. Annu Rev Cell Dev Biol , 2006, 22: 267–286. [20] E, Le Douarin NM. Development of melanocyte precursors from the vertebrate neural crest. Oncogene , 2003, 22(20): 3016–3023. [21] T, Bronner-Fraser M. Development and evolution of the migratory neural crest: a gene regulatory perspective. Curr Opin Genet Dev , 2006, 16(4): 360–366. [22] FC, Kos L. Timeline and distribution of melanocyte precursors in the mouse heart. Pigment Cell Melanoma Res , 2008, 21( |